Skip to main content
Triochem Products Ltd. logo

Triochem Products Ltd. — Investor Relations & Filings

Ticker · 512101 ISIN · INE331E01013 BSE.NS Manufacturing
Open in API
Filings indexed 442 across all filing types
Latest filing 2023-06-02 Regulatory Filings
Country IN India
Listing BSE.NS 512101

About Triochem Products Ltd.

https://www.triochemproducts.com

Triochem Products Ltd. is a manufacturer and exporter specializing in Active Pharmaceutical Ingredients (APIs) and pharmaceutical intermediates. The company focuses on the production of high-quality chemical compounds for the global healthcare and pharmaceutical sectors. Its core product portfolio includes a range of specialized substances such as Quinine salts, Quinidine salts, and other niche therapeutic ingredients. Triochem Products Ltd. emphasizes adherence to stringent quality control measures and international regulatory standards to ensure the efficacy and safety of its chemical outputs. The organization serves a diverse clientele, providing essential raw materials for the formulation of various medications. By leveraging advanced chemical synthesis processes and technical expertise, the company maintains a significant presence in the supply chain for specialized pharmaceutical components.

Recent filings

Filing Released Lang Actions
With reference to your email dated 31st May 2023 regarding the submission of Initial Disclosure / Confirmation by Large Corporate as per Chapter XII of SEBI Circular SEBI/HO/DDHS/CIR/2021/613 ....
Regulatory Filings
2023-06-02 English
This is to inform you that Disclosures of the Related Party Transaction on a consolidated basis under Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) (Amendment) ....
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the stock exchange (BSE Limited) regarding the non-applicability of certain SEBI regulations related to related party transactions and corporate governance provisions. It certifies exemption under Regulation 15(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, based on the company's paid-up equity capital and net worth. The document does not contain financial statements, detailed financial data, or a full report. It is a regulatory compliance disclosure or certification rather than a financial report or announcement of voting results, management changes, or capital changes. The document length is 3287 characters, which is relatively short and primarily a formal notification. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance documents that do not fit other specific categories.
2023-05-29 English
This is to inform you that Annual Secretarial Compliance Report under Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) (Amendment) Regulations, 2018 read with BSE ....
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the BSE Limited Corporate Relationship Department regarding the non-applicability of Regulation 24A of SEBI (LODR) (Amendments) Regulation, 2018. It certifies that the company claims exemption under Regulation 15(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 due to its paid-up equity capital and net worth being below specified thresholds. The document is a compliance-related declaration and does not contain financial statements, audit results, or detailed report data. It is a regulatory announcement informing the stock exchange about the company's exemption status and compliance with listing obligations. The document length is 3274 characters, which is relatively short and consistent with a regulatory filing or announcement rather than a full report. Therefore, it fits best under Regulatory Filings (RNS) as a compliance-related notification rather than an actual report or financial filing.
2023-05-29 English
In compliance to Regulation 47 of SEBI (LODR) Regulation, 2015; We are enclosing herewith extract of newspaper copy of Audited Financial Results for the quarter and year ended March 31, ....
Earnings Release Classification · 90% confidence The document is a communication from Triochem Products Limited to the BSE Limited regarding compliance with Regulation 47 of SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015. It encloses an extract of the newspaper publication of the Audited Financial Results for the quarter and year ended March 31, 2023, which were approved by the Board. The document includes a newspaper extract of the audited financial results, indicating it is an announcement of financial results rather than the full detailed report itself. The document length is about 15,000 characters, but the content is primarily an intimation of the publication of audited financial results in newspapers, which is typical for earnings releases or financial results announcements. However, since it references audited financial results for the quarter and year ended March 31, 2023, and is an official announcement under SEBI regulations, it aligns best with an Earnings Release (ER) category, which is the initial announcement of quarterly/periodical financial results with key highlights. It is not a full Annual Report (10-K) or Interim Report (IR) because it does not contain comprehensive financial statements or detailed analysis, but rather an extract of published results. Therefore, the classification is Earnings Release (ER).
2023-05-28 English
This is to inform you that Disclosures of the Related Party Transaction on a consolidated basis under Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) (Amendment) ....
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the stock exchange (BSE Limited) regarding the non-applicability of certain SEBI regulations related to related party transactions and corporate governance provisions. It certifies exemption under Regulation 15(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, based on the company's paid-up equity capital and net worth. The document does not contain financial statements or detailed financial data but is a regulatory compliance communication. It is relatively short (3284 characters) and serves as a formal notification to the exchange rather than a full report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance documents that do not fit other specific categories.
2023-05-26 English
Outcome of Board Meeting held on Friday, May 26, 2023 Ref: Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015 We would like to inform ....
Regulatory Filings
2023-05-26 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.